Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. It has now been 100 years since the first patient with diabetes received an injection of ...

Despite recent legislation capping insulin prices and manufacturer assistance programs, some people with diabetes who require insulin still encounter barriers to obtaining a reliable supply.

Last year, Eli Lilly, Novo Nordisk and Sanofi dropped their insulin prices between 65% to 80% ... Your support ensures our ...

Over the past decade, the rising cost of insulin epitomized the broader systemic issue of higher healthcare out-of-pocket costs that prevented many Americans from accessing essential care.

Biosimilar insulin glargine access in Europe correlates with significant price reductions of originator products, enhancing affordability and accessibility. The study observed a 21.6% average ...

The Federal Trade Commission and the pharmacy benefit managers it's accusing of artificially inflating insulin prices are hitting a host of prominent companies, from McDonald's to the HR ...

Democratic Senator Scott Wiener from San Francisco recently resurrected a bill — now Senate Bill 40 — to cap insulin prices that Newsom vetoed last year. His veto message said CalRx made it ...

Two years ago, California made a bold announcement that it would manufacture a state-branded, low-cost insulin. Drug manufacturers, insurers, economists and diabetics took notice. It had the ...